|
1.
|
Nagata N, Matsuda I and Oyanagi K:
Estimated frequency of urea cycle enzymopathies in Japan. Am J Med
Genet. 39:228–229. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Takahashi Y, Koyama S, Tanaka H, Arawaka
S, Wada M, Kawanami T, Haga H, Watanabe H, Toyota K, Numakura C, et
al: An elderly Japanese patient with adult-onset type II
citrullinemia with a novel D493G mutation in the SLC25A13 gene.
Intern Med. 51:2131–2134. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Kobayashi K, Sinasac DS, Iijima M, Boright
AP, Begum L, Lee JR, Yasuda T, Ikeda S, Hirano R, Terazono H, et
al: The gene mutated in adult-onset type II citrullinaemia encodes
a putative mitochondrial carrier protein. Nat Genet. 22:159–163.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Song YZ, Zhang ZH, Lin WX, Zhao XJ, Deng
M, Ma YL, Guo L, Chen FP, Long XL, He XL, et al: SLC25A13 gene
analysis in citrin deficiency: Sixteen novel mutations in East
Asian patients, and the mutation distribution in a large pediatric
cohort in China. PLoS One. 8:e745442013. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Kobayashi K, Saheki T and Song YZ: Citrin
Deficiency. GeneReviews. Pagon RA, Bird TD, Dolan CR, Stephens K
and Adam MP: (Seattle, WA). University of Washington. 2005.
|
|
6.
|
Honda S, Yamamoto K, Sekizuka M, Oshima Y,
Nagai K, Hashimoto G, Kaneko H, Tomomasa T, Konno Y and Horiuchi R:
Successful treatment of severe hyperammonemia using sodium
phenylacetate powder prepared in hospital pharmacy. Biol Pharm
Bull. 25:1244–1246. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Sinasac DS, Moriyama M, Jalil MA, Begum L,
Li MX, Iijima M, Horiuchi M, Robinson BH, Kobayashi K, Saheki T and
Tsui LC: Slc25a13-knockout mice harbor metabolic deficits but fail
to display hallmarks of adult-onset type II citrullinemia. Mol Cell
Biol. 24:527–536. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Ikeda S, Yazaki M, Takei Y, Ikegami T,
Hashikura Y, Kawasaki S, Iwai M, Kobayashi K and Saheki T: Type II
(adult onset) citrullinaemia: Clinical pictures and the therapeutic
effect of liver transplantation. J Neurol Neurosurg Psychiatry.
71:663–670. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Takahashi H, Kagawa T, Kobayashi K,
Hirabayashi H, Yui M, Begum L, Mine T, Takagi S, Saheki T and
Shinohara Y: A case of adult-onset type II
citrullinemia-deterioration of clinical course after infusion of
hyperosmotic and high sugar solutions. Med Sci Monit. 12:CS13–CS15.
2006.PubMed/NCBI
|
|
10.
|
Yazaki M, Hashikura Y, Takei Y, Ikegami T,
Miyagawa S, Yamamoto K, Tokuda T, Kobayashi K, Saheki T and Ikeda
S: Feasibility of auxiliary partial orthotopic liver
transplantation from living donors for patients with adult-onset
type II citrullinemia. Liver Transpl. 10:550–554. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Hirai I, Kimura W, Suto K, Fzjimoto H,
Watanabe T, Fuse A, Kobayashi K, Iijima M, Saheki T, Nakatsuka T,
et al: Living donor liver transplantation for type II citrullinemia
from a heterozygous donor. Hepatogastroenterology. 55:2211–2216.
2008.PubMed/NCBI
|
|
12.
|
Kobayashi K and Saheki T: Molecular basis
of citrin deficiency. Seikagaku. 76:1543–1559. 2004.(In Japanese).
PubMed/NCBI
|
|
13.
|
Imamura Y, Kobayashi K, Shibatou T,
Aburada S, Tahara K, Kubozono O and Saheki T: Effectiveness of
carbohydrate-restricted diet and arginine granules therapy for
adult-onset type II citrullinemia: A case report of siblings
showing homozygous SLC25A13 mutation with and without the disease.
Hepatol Res. 26:68–72. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Saheki T, Kobayashi K, Iijima M, Horiuchi
M, Begum L, Jalil MA, Li MX, Lu YB, Ushikai M, Tabata A, et al:
Adult-onset type II citrullinemia and idiopathic neonatal hepatitis
caused by citrin deficiency: Involvement of the aspartate glutamate
carrier for urea synthesis and maintenance of the urea cycle. Mol
Genet Metab. 81(Suppl 1): S20–S26. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Yazaki M, Takei Y, Kobayashi K, Saheki T
and Ikeda S: Risk of worsened encephalopathy after intravenous
glycerol therapy in patients with adult-onset type II citrullinemia
(CTLN2). Intern Med. 44:188–195. 2005. View Article : Google Scholar : PubMed/NCBI
|
